CUFinder

Jerzy Jankun, DSc, PhD

Jerzy Jankun, DSc, PhD

University of Toledo

H-index: 36

North America-United States

About Jerzy Jankun, DSc, PhD

Jerzy Jankun, DSc, PhD, With an exceptional h-index of 36 and a recent h-index of 18 (since 2020), a distinguished researcher at University of Toledo, specializes in the field of biochemistry, cancer, bleeding, diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach

COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.

Jerzy Jankun, DSc, PhD Information

University

Position

Professor Department of Urology The

Citations(all)

4829

Citations(since 2020)

1137

Cited By

4184

hIndex(all)

36

hIndex(since 2020)

18

i10Index(all)

86

i10Index(since 2020)

32

Email

Access Email

University Profile Page

University of Toledo

Google Scholar

View Google Scholar Profile

Jerzy Jankun, DSc, PhD Skills & Research Interests

biochemistry

cancer

bleeding

diabetes

Top articles of Jerzy Jankun, DSc, PhD

Title

Journal

Author(s)

Publication Date

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach

Translation: The University of Toledo Journal of Medical Sciences

Benjamin Talbot

Jerzy Jankun

2020/5/6

COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.

Translation: The University of Toledo Journal of Medical Sciences

Jerzy Jankun

2020/4/24

See List of Professors in Jerzy Jankun, DSc, PhD University(University of Toledo)